Navigation Links
i-STAT Portable Clinical Analyzer

Productsi-STAT Portable Clinical Analyzer
Company Abbott Diagnostics
Item i-STAT Portable Clinical Analyzer
Features 
  • Stores up to 50 patient records
  • On-screen viewing of test results
  • Transmission of records to a data management system
Description The i-STAT Portable Clinical Analyzer (PCA) is used in conjunction with disposable cartridges for determination of a variety of parameters in whole blood. The analyzer stores up to 50 patient records and permits on-screen viewing of test results as well as transmission of records to a data management system using infrared signals.
Info Abbott Diagnostics
Customer Service: (847) 937-6100
Web site: http://www.abbottdiagnostics.com/

Related medicine products :

1. i-STAT 1
2. Safe-Wrap Combo Blood Collection Tubes (For the i-STAT® System)
3. Portable Mini Halogen Light
4. View Mex-2 Portable Xenon Headlight
5. View Mex-3 Portable Xenon Headlight
6. Portable ABI Kit
7. Topcon Portable System
8. Suzanne Portable Recording System
9. CXDI-31 Portable DR System
10. CXDI-50G Portable DR System
11. Portable Operation Microscope
...orporate a layered design unique in the industry. ...ent stray electrosurgical burns along the shaft of...pacitive coupling; a well-documented patient safet...nstruments provides a neutral return path for capa...
...orporate a layered design unique in the industry. ...ent stray electrosurgical burns along the shaft of...pacitive coupling; a well-documented patient safet...nstruments provides a neutral return path for capa...
...orporate a layered design unique in the industry. ...ent stray electrosurgical burns along the shaft of...pacitive coupling; a well-documented patient safet...nstruments provides a neutral return path for capa...
The Auto Suture™ ExtraHand™ balloon retractor is designed to be used during open surgery, gasless endoscopy, as well as endoscopy with gas insufflation.
Medicine Products:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...y—the granting of exclusive rights to commercial c...could jeopardize efforts to create generic version...h, says Karin Timmermans of the World Health Organ...cine. Writing in a personal capacity, Ms Timmerma...
...ought, but the fear has to be dealt with, at least...sts working for Missouri-Columbia University have ...obesity to common everyday chemicals, found in pla...ederick vom Saal, lead researcher, sounding his vi...
...emature baby are thanking doctors who clutched at ...o resurrect his lungs.// Little Lewis Longfellow ... 24 weeks of pregnancy. His premature birth couple... enough, but this was worsened when his lungs coll...
...has found supporting evidence to implicate insulin...opment of Graves’ disease.// In a previous resear..., Ph.D. had identified the interaction between imm...inflammation and lymphocyte infiltration in both G...
Other Medicine News:Health News:Drug Companies Should Not Have a Monopoly Over Clinical Trial Data 2Health News:Be Careful What You Touch, It can Make You Fat 2Health News:Viagra Plays Another Role-Premature Baby Saved 2Health News:A Single Biological Mechanism Behind Several Autoimmune Disorders 2
(Date:9/3/2008)...gium and GENEVA, Sept. 3 /- Artelis S...n CHO based monoclonal antibody,production with th...rams,per liter. This record level was accomplished...1) a high-performance stable Selexis CHO,productio...scientists at,Selexis SA using their proprietary S...
(Date:9/3/2008)...howed that Multaq(R) (dronedarone) decreased the r...lation or atrial flutter already adeq...ATER, N.J., Sept. 3 /- The ...e ATHENA study were presented today at,the clinica...Cardiology,congress 2008, in Munich, Germany. Prev...
(Date:9/3/2008)...es Operations, Updates Zingo Launch Progress and A... Conference Call Today at 11:30 a...swire-FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV )...,operations to focus on commercial and late-stage ...o a specialty pharmaceutical pain management,compa...
(Date:9/3/2008)... Evaluated in Repeat-Dosing Study in Subjects with...Call/ -- Sangamo,BioSciences, Inc. (Nasdaq: SGMO ...nical trial (SB-509-801) to evaluate its drug, SB-...tive motor-neuron disease for which there,are limi...g, SB-509, is an injectable formulation of a plasm...
Breaking Medicine Technology:Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5How schizophrenia develops 3A Major clues discovered 841 1How schizophrenia develops 3A Major clues discovered 841 2The Childrens Institute Launches The Campaign for an Amazing Future 3862 1The Childrens Institute Launches The Campaign for an Amazing Future 3862 2The Childrens Institute Launches The Campaign for an Amazing Future 3862 3Edwards Lifesciences Announces Schedule of Activities at TCT 2007 3858 1Edwards Lifesciences Announces Schedule of Activities at TCT 2007 3858 2Edwards Lifesciences Announces Schedule of Activities at TCT 2007 3858 3Edwards Lifesciences Announces Schedule of Activities at TCT 2007 3858 4Ohio Delegation Members Urge Colleagues to Vote for Override of SCHIP Veto 3854 1Ohio Delegation Members Urge Colleagues to Vote for Override of SCHIP Veto 3854 2
...wswire/ -- Portola,Pharmaceuticals, Inc. announced...54021, an oral Factor Xa inhibitor, today at the X...osis and Haemostasis,(ISTH) in Geneva, Switzerland... effective, and well tolerated for the,prevention ...undergoing total knee replacement (TKR) surgery. P...
...or for U.S. Trial -, MISSISSAUGA, ON, July 11, 200...n oncology company that identifies, develops,and c... worldwide,today announced results of secondary e...ebo-controlled, multi-center Phase IIb,trial (DLXL...,inhaled-delivery composition of free and liposome...
Other Medicine Technology:Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 2YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 3YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 4YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 5